Related Experiment Videos
Bleeding from endometrial and vaginal malignant tumors treated with activated recombinant factor VII
S Sajdak1, R Moszynski, T Opala
1Department of Gynecology and Obstetrics, Karol Marcinkowski University of Medical Sciences, Poznan, Poland. Kgo@gpsk.am.poznan.pl
European Journal of Gynaecological Oncology
|September 7, 2002
Abstract:
The authors report two cases of successful employment of human recombinant activated factor VII in gynecological oncological patients (endometrial cancer and vaginal sarcoma) without pre-existing coagulopathy. They conclude that recombinant factor VIIa may be an important and effective drug in severe bleeding in gynecological oncology.